BioSpace News Archive

Initiated IND-enabling studies for FTX-6058 for the potential treatment of sickle cell disease and beta-thalassemia and announced pre-clinical data showing increase in HbF levels to ~30% of total hemoglobin

Kizoo Technology Capital leads seed round financing at Underdog Pharmaceuticals

Anavex Life Sciences Corp. announced that it received the Rare Pediatric Disease designation from the U.S. Food and Drug Administration for ANAVEX®2-73 for the treatment of Rett syndrome, a rare genetic neurological disorder associated with severe physical and cognitive impairments that afflicts mostly girls.

Trillium Therapeutics Inc. reported financial results for the nine months ended September 30, 2019, and provided a corporate update.

Record consolidated revenues at $32.8 M for FY2019 compared with $24.1 M for FY2018, a 36% increase

Milestone Pharmaceuticals Inc. announced that Joseph G. Oliveto, President and Chief Executive Officer, will present at the following investor conferences

DKN-01 data continues to show robust activity, including a monotherapy complete response, in cancer patients with high DKK-1 expression and Wnt signaling alterations

Seneca Biopharma, Inc., a clinical-stage biopharmaceutical company developing novel treatments for various diseases of high unmet medical need, reported its financial results for the three and nine months ended September 30, 2019.

Seres Therapeutics, Inc. announced that it will present at the Stifel 2019 Healthcare Conference in New York City on Tuesday, November 19 at 9:10 a.m. ET.

IVERIC bio, Inc. announced details for its previously announced Zimura® R&D Symposium for Investors being held in New York, NY on Wednesday, November 20, 2019, from 8:00 a.m. to 10:00 a.m. ET.